Skip to the page

Data / Form D filings / Cognito Therapeutics Ltd.

Cognito Therapeutics Ltd.: Form D filings

Cognito Therapeutics Ltd., a health care company in Cambridge, MA, filed 3 Form D notices with the SEC between 2022 and 2024. The latest, on July 2, 2024, reports $10.2 million sold of a $60 million offering to 3 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1218 MASSACHUSETTS AVE, SUITE 200, Cambridge, MA, 02138
Phone
(857) 201-5088
Industry
Other Health Care
Entity type
Other (Exempted Company)
Incorporated in
Cayman Islands
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1936187

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jul 2, 2024New notice$60,032,626$10,249,997$49,782,6293Jun 18, 2024sec.gov
Nov 15, 2023Amendment$126,175,917$108,765,300$17,410,61713Jun 16, 2022sec.gov
Jul 1, 2022New notice$126,175,917$53,332,027$72,843,8909Jun 16, 2022sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Brent VaughanExecutive Officer, Director
Helen LiangDirector
Stephen BrusoDirector
Jeffrey HalisDirector
Gerald ChanDirector
Richard KuntzDirector
Laura BregeDirector

Other health care companies in Massachusetts that filed recently

Every Form D from the week of Jul 1, 2024 · All recent filings in Massachusetts · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Cognito Therapeutics Ltd. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.